Copyright
©The Author(s) 2020.
World J Cardiol. Nov 26, 2020; 12(11): 513-525
Published online Nov 26, 2020. doi: 10.4330/wjc.v12.i11.513
Published online Nov 26, 2020. doi: 10.4330/wjc.v12.i11.513
Ref. | Cohort | Mean age (yr) | Invasive strategy (%) | In-hospital mortality (%) | Major bleeding (%) | MACEs (%) |
Rosengren et al[13], 2006 | NSTE-ACS, STE-ACS | N/A; 25% of patients > 75 yr | 34.6 | 4.7; 9.7 in patients 75 yr | N/A | N/A |
Devlin et al[22], 2008 | NSTE-ACS | 66 | 38 | 5.8 | 2.4 | 9.2 |
Nagata et al[19], 2017 | NSTE-ACS (Elderly group 80 yr) | 73 | 79 | 8.5 | 0 | 9.9 |
Toleva et al[32], 2015 | STE-ACS (Elderly group 75 yr) | 82.2 | 70.1 | 14.2 | 13 | 27.6 |
- Citation: Rondano E, Bertolazzi M, Galluzzo A, Maltese L, Caccianotti P, Macciò S, Mazza S, Di Ruocco MV, Favretto S, Occhetta E, Rametta F. Effectiveness and safety of antithrombotic strategies in elderly patients with acute myocardial infarction. World J Cardiol 2020; 12(11): 513-525
- URL: https://www.wjgnet.com/1949-8462/full/v12/i11/513.htm
- DOI: https://dx.doi.org/10.4330/wjc.v12.i11.513